These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 11206672)
1. A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning. Smith DH; Neutel JM; Weber MA Am J Hypertens; 2001 Jan; 14(1):14-9. PubMed ID: 11206672 [TBL] [Abstract][Full Text] [Related]
2. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131 [TBL] [Abstract][Full Text] [Related]
3. Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning. Neutel JM; Alderman M; Anders RJ; Weber MA Am Heart J; 1996 Dec; 132(6):1202-6. PubMed ID: 8969572 [TBL] [Abstract][Full Text] [Related]
4. A steady-state evaluation of the bioavailability of chronotherapeutic oral drug absorption system verapamil PM after nighttime dosing versus immediate-acting verapamil dosed every eight hours. Prisant LM; Devane JG; Butler J Am J Ther; 2000 Nov; 7(6):345-51. PubMed ID: 11304641 [TBL] [Abstract][Full Text] [Related]
5. Chronotherapeutic delivery of verapamil in obese versus non-obese patients with essential hypertension. White WB; Elliott WJ; Johnson MF; Black HR J Hum Hypertens; 2001 Feb; 15(2):135-41. PubMed ID: 11317194 [TBL] [Abstract][Full Text] [Related]
6. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising. White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology of cardiovascular chronotherapeutic agents. Smith DH Am J Hypertens; 2001 Sep; 14(9 Pt 2):296S-301S. PubMed ID: 11583143 [TBL] [Abstract][Full Text] [Related]
8. Chrono: a community-based hypertension trial of a chronotherapeutic formulation of verapamil. Prisant LM; Black HR; Messerli F; Weber M Am J Ther; 2002; 9(6):476-83. PubMed ID: 12424503 [TBL] [Abstract][Full Text] [Related]
9. Chronotherapeutic oral drug absorption system verapamil is effective in reducing morning blood pressure in African Americans: a post hoc analysis of the chrono trial. Prisant LM; Weber M; Black HR J Natl Med Assoc; 2005 Mar; 97(3):377-83. PubMed ID: 15779502 [TBL] [Abstract][Full Text] [Related]
10. Effects of the chronotherapeutic delivery of verapamil on circadian blood pressure in African-American patients with hypertension. White WB; Johnson MF; Black HR; Fakouhi TD Ethn Dis; 1999; 9(3):341-9. PubMed ID: 10600056 [TBL] [Abstract][Full Text] [Related]
11. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product. White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593 [TBL] [Abstract][Full Text] [Related]
12. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy. White WB; Johnson MF; Black HR; Elliott WJ; Sica DA Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133 [TBL] [Abstract][Full Text] [Related]
13. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension. Muijsers RB; Curran MP; Perry CM Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112 [TBL] [Abstract][Full Text] [Related]
14. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes. Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861 [TBL] [Abstract][Full Text] [Related]
15. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Hermida RC; Ayala DE; Mojón A; Fernández JR Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215 [TBL] [Abstract][Full Text] [Related]
16. Treatment of elderly hypertensive patients with a delayed-release verapamil formulation in a community-based trial. Weber MA; Prisant LM; Black HR; Messerli FH Am J Geriatr Cardiol; 2004; 13(3):131-6. PubMed ID: 15133416 [TBL] [Abstract][Full Text] [Related]
17. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study. Veratran Study Group Am J Hypertens; 1997 May; 10(5 Pt 1):492-9. PubMed ID: 9160758 [TBL] [Abstract][Full Text] [Related]
18. Serum concentration and antihypertensive effect of slow-release verapamil. Schütz E; Ha HR; Bühler FR; Follath F J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S346-9. PubMed ID: 6184566 [TBL] [Abstract][Full Text] [Related]
19. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study. Shimada K; Ogihara T; Saruta T; Kuramoto K; Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495 [TBL] [Abstract][Full Text] [Related]
20. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects. Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]